Tag Archives: JAKK

Best Safest Stocks To Invest In Right Now

Go back a year, and offshore drillers like Noble (NE), Rowan (RDC), Transocean (RIG) and Atwood Oceanics (ATW) had been all but written off–until they weren’t anymore. Since then, investors have been rewarded for picking winners in the group from the losers, as Atwood Oceanics has more than doubled, Transocean has gained 34%, and Rowan has risen 42%, while Noble and Diamond Offshore Drilling (DO) have dropped 13%.

Agence France-Presse/Getty Images

But are the days of picking stocks among offshore drillers over? Consider: Today, Jefferies analyst Eduardo Royes and team upgraded Noble to Buy and cut Rowan to Hold, clearly favoring one over the other. They explain why:

Given where we sit in the cycle, we cannot favorably recommend the group. That said, we can still see relative value (or lack thereof) in shares. We upgrade Noble to Buy as we view it as the ‘safest’ way to play offshore drilling exposure at the moment —we see modest upside to shares on a DCF and relative valuation basis. Meanwhile we downgrade Rowan to Hold as despite still generating healthy free cash flow, we see risk that medium-term earnings disappoint (we’re >30% below ’18 Street EBITDA) as the ‘turn’ in jackups and ultra-deep-water markets is likely challenged from a profitability standpoint. Outside of Rowan and Noble, we skew favorably to Hold-rated Ensco (ESV) and Transocean.

Best Safest Stocks To Invest In Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Stephan Byrd]

    Partner Communications (NASDAQ: PTNR) and Cellcom Israel (NYSE:CEL) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

Best Safest Stocks To Invest In Right Now: S&P GSCI(GD)

Advisors’ Opinion:

  • [By Lou Whiteman]

    General Dynamics (NYSE:GD) has been the “wait ’til next year” story of the defense industry for several years now. The company’s initial guidance for 2019 suggests that investors are going to need to be patient a while longer.

  • [By Lee Jackson]

    This company, like other major defense prime contractors, had a very solid year and is also on the Merrill Lynch US 1 list. General Dynamics Corp. (NYSE: GD) is engaged in business aviation, land and expeditionary combat vehicles and systems, armaments, munitions, shipbuilding and marine systems, and information systems and technologies.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on General Dynamics (GD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Safest Stocks To Invest In Right Now: Sundance Energy Australia Limited (SNDE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on SUNDANCE ENERGY/S (SNDE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    CASIO COMPUTER/ADR (OTCMKTS:CSIOY) and SUNDANCE ENERGY/S (NASDAQ:SNDE) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

  • [By Ethan Ryder]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get SUNDANCE ENERGY/S alerts:

    SUNDANCE ENERGY/S (SNDE) Expected to Post Quarterly Sales of $31.40 Million (americanbankingnews.com) -$0.06 Earnings Per Share Expected for SUNDANCE ENERGY/S (SNDE) This Quarter (americanbankingnews.com) Sundance Energy Australia (NASDAQ: SNDE) – Day Three Breakout Notes (oilandgas360.com) Sundance Energy Australia (SNDE) Presents At EnerCom’s 23rd Annual Oil & Gas Conference – Slideshow (seekingalpha.com)

    SNDE has been the topic of a number of research analyst reports. Zacks Investment Research downgraded SUNDANCE ENERGY/S from a “hold” rating to a “sell” rating in a research report on Wednesday, June 27th. ValuEngine upgraded SUNDANCE ENERGY/S from a “sell” rating to a “hold” rating in a research report on Saturday, June 16th. Finally, Seaport Global Securities reiterated a “buy” rating on shares of SUNDANCE ENERGY/S in a research report on Monday, August 13th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $7.30.

Best Safest Stocks To Invest In Right Now: Vanguard Extended Duration Treasury ETF (EDV)

Advisors’ Opinion:

  • [By ]

    My preferred fund here is Vanguard Extended Duration Treasury ETF (NYSE: EDV), which owns a basket of long-term, zero-coupon bonds. It’s better-known, larger, and, most important, cheaper than its competitor PIMCO 25+ Year Zero Coupon U.S. Treasury Index Exchange-Traded Fund (NYSE: ZROZ). Both are poised to rally if deflation hits and the stock market falls. But EDV is cheaper, at only 0.07% expense ratio, compared with ZROZ’s 0.15%, and so it’s the one that makes the cut.

  • [By Peter Graham]

    Sandstorm’s due diligence is thorough, they don’t just invest in any company. They like West Africa because they understand the area and the opportunities that exist there. Sandstorm is a royalty and streaming company, so they make these investments and receive cashflow deals that often kick in much later on. But they have already established a presence in Burkina and have deals in place with larger companies like Orezone Gold (TSXV: ORE) and Endeavour Mining (TSX: EDV). Sandstorm’s investment also potentially gives us access to their marketing department through something they call Launch Lab, and it looks like it will really benefit our own marketing efforts and will expose us to more opportunities over the coming year.

Best Safest Stocks To Invest In Right Now: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.iShares Russell 2000 (IWM) – 1,060,000 shares, 73.71% of the total portfolio. Stonemor Partners LP (STON) – 6,650,613 shares, 17.03% of the total portfolio. Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 5.58% of the total portfolio. Stage Stores Inc (SSI) – 2,115,200 shares, 2.16% of the total portfolio. Shares added by 20.87%Five Star Senior Living Inc (FVE) – 2,073,398 shares, 1.32% of the total portfolio. Shares added by

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    JAKKS Pacific, Inc. (NASDAQ:JAKK) was the recipient of a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,973,265 shares, a decline of 38.2% from the July 31st total of 3,191,567 shares. Based on an average daily volume of 91,634 shares, the days-to-cover ratio is currently 21.5 days. Approximately 11.4% of the company’s shares are sold short.

Best Safest Stocks To Invest In Right Now: Aehr Test Systems(AEHR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aehr Test Systems (AEHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Aehr Test Systems (NASDAQ:AEHR) insider David S. Hendrickson sold 5,000 shares of the stock in a transaction dated Tuesday, May 22nd. The shares were sold at an average price of $2.37, for a total transaction of $11,850.00. Following the completion of the sale, the insider now owns 25,351 shares of the company’s stock, valued at approximately $60,081.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Max Byerly]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get Aehr Test Systems alerts:

    Critical Comparison: Data I/O (DAIO) & Aehr Test Systems (AEHR) (americanbankingnews.com) Form 4 AEHR TEST SYSTEMS For: May 08 Filed by: HENDRICKSON DAVID S (streetinsider.com) Aehr Test Systems (AEHR) CTO David S. Hendrickson Sells 5,000 Shares (americanbankingnews.com) Teradyne (TER) versus Aehr Test Systems (AEHR) Head to Head Review (americanbankingnews.com) Insider Selling: Aehr Test Systems (AEHR) Insider Sells 20,000 Shares of Stock (americanbankingnews.com)

    AEHR remained flat at $$2.28 during trading hours on Monday. The company had a trading volume of 64,100 shares, compared to its average volume of 136,351. Aehr Test Systems has a 52 week low of $2.26 and a 52 week high of $2.28. The stock has a market cap of $50.06 million, a price-to-earnings ratio of -7.86 and a beta of 0.82. The company has a current ratio of 4.62, a quick ratio of 3.20 and a debt-to-equity ratio of 0.33.

Top Undervalued Stocks To Watch Right Now

Organovo Holdings (NASDAQ:ONVO) is a small biotech company that aims to create functional human tissue using its proprietary three-dimensional bioprinting technology. The company’s long-term goal is to build living human tissue that functions like real tissue and can even be used for transplant.

Needless to say that if the company succeeds, it will be a game-changer for the development of ground-breaking therapies worldwide. However, like many biotech companies, it is still in the early stage of development.

Two reasons why I love stocks like Organovo Holdings

For starters, if it succeeds, it might mean a lot of money for shareholders. This is because it is starting from a very low valuation (about $160M). So, the slightest positive development might mean a substantial rise for its stock from today’s levels.

The second reason I like ONVO is because everybody who has ever invested in its stock has lost money over the years. And the reason why I like such stocks is because, after many years of losses, investors give up, and such stocks usually become extremely undervalued. This is why sometimes long forgotten stocks become great opportunities.

Top Undervalued Stocks To Watch Right Now: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Merit Medical Systems (NASDAQ:MMSI) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.97-2.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.97. The company issued revenue guidance of $1.011-1.03 billion, compared to the consensus revenue estimate of $1.01 billion.

  • [By Max Byerly]

    Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $52.00.

  • [By Logan Wallace]

    Bank of America cut shares of Merit Medical Systems (NASDAQ:MMSI) from a buy rating to an underperform rating in a report published on Tuesday morning, MarketBeat reports. They currently have $64.00 price target on the medical instruments supplier’s stock.

  • [By Ethan Ryder]

    BNP Paribas Arbitrage SA lessened its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 54.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,272 shares of the medical instruments supplier’s stock after selling 8,717 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Merit Medical Systems were worth $372,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Undervalued Stocks To Watch Right Now: Clean Energy Fuels Corp.(CLNE)

Advisors’ Opinion:

  • [By Jason Hall]

    Natural gas for transportation supplier Clean Energy Fuels Corp (NASDAQ:CLNE) reported earnings on May 10, and while the company was profitable on both a GAAP and adjusted basis, growth — measured in gallons of natural gas delivered — slowed to almost a trickle, even when adjusted for last year’s sale of the biomethane business. At the same time, the cyclical nature of its station construction and expansion business also affected the results, playing a role in a big decline in revenue. 

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Paul Ausick]

    Clean Energy Fuels Corp. (NASDAQ: CLNE) saw a drop of 9.8% in short interest to 2.99 million shares. About 2.2% of the company’s float was short, and days to cover slipped from eight to seven. The share price was unchanged in the period, although it dipped about 10% before regaining its starting point. The stock closed at $2.24 on Wednesday, up about 2.3% for the day, in a 52-week range of $1.31 to $4.05.

  • [By Tyler Crowe, Jason Hall, and Matthew DiLallo]

    So we asked three of our Motley Fool contributors to each highlight a stock they think is a top buy this month. Here’s why they picked Williams Companies (NYSE:WMB), Clean Energy Fuels (NASDAQ:CLNE), and SolarEdge Technologies (NASDAQ:SEDG)

Top Undervalued Stocks To Watch Right Now: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Headlines about JAKKS Pacific (NASDAQ:JAKK) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. JAKKS Pacific earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.746095708984 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Joseph Griffin]

    JAKKS Pacific, Inc. (NASDAQ:JAKK) – Equities research analysts at Jefferies Financial Group raised their Q2 2018 EPS estimates for JAKKS Pacific in a report issued on Monday, June 18th. Jefferies Financial Group analyst S. Wissink now expects that the company will earn ($0.50) per share for the quarter, up from their prior forecast of ($0.63). Jefferies Financial Group also issued estimates for JAKKS Pacific’s Q4 2018 earnings at ($0.31) EPS, FY2018 earnings at ($0.56) EPS, Q3 2019 earnings at $0.50 EPS and FY2019 earnings at $0.05 EPS.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.iShares Russell 2000 (IWM) – 1,060,000 shares, 73.71% of the total portfolio. Stonemor Partners LP (STON) – 6,650,613 shares, 17.03% of the total portfolio. Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 5.58% of the total portfolio. Stage Stores Inc (SSI) – 2,115,200 shares, 2.16% of the total portfolio. Shares added by 20.87%Five Star Senior Living Inc (FVE) – 2,073,398 shares, 1.32% of the total portfolio. Shares added by

Hot Warren Buffett Stocks To Own For 2019

Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has one of the most closely followed stock portfolios in the world, and for good reason. Many of the stocks in it were hand-selected by billionaire investor Warren Buffett.

While I wouldn’t go so far as to say that all of these “Buffett stocks” are great buys, there are some that really stand out right now. Here are two in particular — an investment bank that’s quietly getting into the consumer side of the business, and an automaker that’s more of a disruptor than the market gives it credit for — that look extremely attractive as we head in to July.

Image Source: The Motley Fool.

Company (Symbol)

Recent Stock Price

Dividend Yield

Goldman Sachs (NYSE:GS)

$223.26

1.4%

Hot Warren Buffett Stocks To Own For 2019: Mechel OAO(MTL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Mullen Group Ltd (TSE:MTL) declared a monthly dividend on Wednesday, June 20th, Zacks reports. Shareholders of record on Saturday, June 30th will be paid a dividend of 0.05 per share on Monday, July 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date of this dividend is Thursday, June 28th.

  • [By Logan Wallace]

    Media coverage about Mechel PAO (NYSE:MTL) has been trending somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Mechel PAO earned a news impact score of 0.17 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 45.3523753315597 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Max Byerly]

    News headlines about Chelyabinsk Metallurgical Plant (NYSE:MTL) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Chelyabinsk Metallurgical Plant earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news articles about the basic materials company an impact score of 46.5001512376479 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Hot Warren Buffett Stocks To Own For 2019: Las Vegas Sands Corp.(LVS)

Advisors’ Opinion:

  • [By Rich Duprey]

    Even if Macau’s casino market is slowing, it has proven to be a lucrative business for global operators like Wynn Resorts (NASDAQ:WYNN) and Las Vegas Sands (NYSE:LVS), which derive most of their revenue from the enclave, the only place in China where it is legal to gamble.

  • [By Logan Wallace]

    Las Vegas Sands Corp. (NYSE:LVS) shares hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $80.90 and last traded at $80.53, with a volume of 180232 shares traded. The stock had previously closed at $79.44.

  • [By WWW.GURUFOCUS.COM]

    For the details of Capital Impact Advisors, LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Capital+Impact+Advisors%2C+LLC

    These are the top 5 holdings of Capital Impact Advisors, LLCAmazon.com Inc (AMZN) – 5,132 shares, 2.59% of the total portfolio. Alphabet Inc (GOOGL) – 5,445 shares, 2.48% of the total portfolio. Facebook Inc (FB) – 30,133 shares, 2.3% of the total portfolio. Steel Dynamics Inc (STLD) – 90,034 shares, 1.68% of the total portfolio. Apple Inc (AAPL) – 19,376 s

  • [By Stephan Byrd]

    Wyndham Hotels & Resorts (NYSE: WH) and Las Vegas Sands (NYSE:LVS) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

Hot Warren Buffett Stocks To Own For 2019: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    JAKKS Pacific, Inc. (NASDAQ:JAKK) was the recipient of a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,973,265 shares, a decline of 38.2% from the July 31st total of 3,191,567 shares. Based on an average daily volume of 91,634 shares, the days-to-cover ratio is currently 21.5 days. Approximately 11.4% of the company’s shares are sold short.

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.iShares Russell 2000 (IWM) – 1,060,000 shares, 73.71% of the total portfolio. Stonemor Partners LP (STON) – 6,650,613 shares, 17.03% of the total portfolio. Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 5.58% of the total portfolio. Stage Stores Inc (SSI) – 2,115,200 shares, 2.16% of the total portfolio. Shares added by 20.87%Five Star Senior Living Inc (FVE) – 2,073,398 shares, 1.32% of the total portfolio. Shares added by

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Jakks Pacific (NASDAQ:JAKK) from a sell rating to a hold rating in a research report released on Saturday.

    Several other brokerages have also recently weighed in on JAKK. Stifel Nicolaus lowered their target price on Jakks Pacific from $2.70 to $2.50 and set a hold rating on the stock in a report on Friday, April 27th. Zacks Investment Research cut Jakks Pacific from a hold rating to a sell rating in a report on Monday, April 30th. Finally, BMO Capital Markets restated a market perform rating and set a $2.50 target price (down from $3.50) on shares of Jakks Pacific in a report on Friday, February 23rd. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Jakks Pacific has a consensus rating of Hold and a consensus target price of $2.69.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Warren Buffett Stocks To Own For 2019: MiMedx Group, Inc(MDXG)

Advisors’ Opinion:

  • [By Paul Ausick]

    MiMedX Group Inc. (NASDAQ: MDXG) dropped about 29% Thursday to post a new 52-week low of $5.80. Shares closed at $8.21 on Wednesday and the stock’s 52-week high is $18.25. The biomedical company will restate financial reports filed for more than the last five years. The company’s CFO and its controller and treasurer were both fired Wednesday.

  • [By Brian Feroldi]

    In response to an announcement of a series of leadership and business changes, shares of MiMedx Group (NASDAQ:MDXG), a beaten-down biopharmaceutical company that is focused on regenerative medicine, fell 31% as of 10:25 a.m. EDT Monday.

  • [By Paul Ausick]

    MiMedx Group Inc. (NASDAQ: MDXG) traded down about 10% Thursday and posted a new 52-week low of $4.95 after closing Wednesday at $5.50. The stock’s 52-week high is $18.25. Volume totaled over 3 million, 15% above the daily average of around  2.6 million. The company had no specific news.

  • [By Paul Ausick]

    MiMedx Group Inc. (NASDAQ: MDXG) fell about 7.7% Friday to post a new 52-week low of $3.47. Shares closed at $3.76 on Thursday. The 52-week high is $18.25. Volume of around 3.5 million was about 15% above the daily average. The company had no specific news.

Hot Warren Buffett Stocks To Own For 2019: MediWound Ltd.(MDWD)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Mediwound (MDWD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Media coverage about Mediwound (NASDAQ:MDWD) has been trending somewhat positive on Saturday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Mediwound earned a news impact score of 0.17 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 47.1925876006011 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Mediwound (MDWD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Ethan Ryder]

    Mediwound (NASDAQ: MDWD) and True Drinks (OTCMKTS:TRUU) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Hot Warren Buffett Stocks To Own For 2019: New Relic, Inc.(NEWR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New Relic (NYSE:NEWR) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.10-$0.12 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.01. The company issued revenue guidance of $104.5-$106.5 million, compared to the consensus revenue estimate of $103.12 million.New Relic also updated its FY19 guidance to $0.29-$0.37 EPS.

  • [By Ethan Ryder]

    New Relic Inc (NYSE:NEWR) CFO Mark Sachleben sold 3,370 shares of the business’s stock in a transaction dated Thursday, August 16th. The shares were sold at an average price of $102.17, for a total value of $344,312.90. Following the completion of the sale, the chief financial officer now directly owns 3,433 shares of the company’s stock, valued at approximately $350,749.61. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

  • [By ]

    Tech has simply become too good to ignore, especially with stocks like Micron Technology (MU) up 24% for the year and New Relic (NEWR) soaring 14% today on great earnings.

  • [By Logan Wallace]

    Deutsche Bank assumed coverage on shares of New Relic (NYSE:NEWR) in a report issued on Monday, Marketbeat reports. The brokerage issued a buy rating and a $125.00 target price on the software maker’s stock.

Top 5 Casino Stocks To Own For 2019

From the late 1990s through the early 2010s, Las Vegas Sands (NYSE:LVS) was one of the best growth companies in the gaming industry. It expanded in Las Vegas, Macau, and Singapore, becoming the largest publicly traded gaming company in the world.

Today, investors looking at the casino resort operator don’t see a growth company at all, and they shouldn’t. It has transitioned into a cash-flow machine, and that’s why I think it’s time to look at Las Vegas Sands’ dividend as a great buy in the gaming industry.

Image source: Las Vegas Sands.

The growth days are over… and that’s OK

Las Vegas Sands was in expansion mode from the time The Venetian Las Vegas opened in 1999 until The Parisian in Macau was completed in 2016. Throughout that period, the company was constantly planning or building new resorts. But there aren’t any new projects on the horizon now, and Las Vegas Sands has entered a phase of its life where it may not grow at all.

Top 5 Casino Stocks To Own For 2019: Western Copper and Gold Corporation(WRN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Western Copper (NYSEAMERICAN:WRN) (TSE:WRN) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 367,976 shares, an increase of 17.9% from the May 31st total of 312,021 shares. Based on an average daily trading volume, of 131,386 shares, the short-interest ratio is currently 2.8 days.

Top 5 Casino Stocks To Own For 2019: New Oriental Education & Technology Group, Inc.(EDU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    EduCoin (CURRENCY:EDU) traded up 2.1% against the dollar during the twenty-four hour period ending at 13:00 PM ET on July 6th. EduCoin has a market capitalization of $0.00 and $3.81 million worth of EduCoin was traded on exchanges in the last day. One EduCoin token can currently be bought for approximately $0.0016 or 0.00000025 BTC on major cryptocurrency exchanges. Over the last seven days, EduCoin has traded up 15.1% against the dollar.

  • [By Motley Fool Staff]

    In the following segment, we dive into the education industry and the artificial intelligence tools being used by New Oriental Education (NYSE:EDU) and Chegg(NYSE:CHGG) to boost revenue.

  • [By Joseph Griffin]

    EduCoin (EDU) is a PoW/PoS token that uses the Keccak hashing algorithm. It launched on September 9th, 2017. EduCoin’s total supply is 15,000,000,000 tokens. EduCoin’s official Twitter account is @PReducoin. The official website for EduCoin is www.edu.one.

  • [By Ethan Ryder]

    EduCoin (EDU) is a PoW/PoS token that uses the Keccak hashing algorithm. It launched on September 9th, 2017. EduCoin’s total supply is 15,000,000,000 tokens. EduCoin’s official website is www.edu.one. EduCoin’s official Twitter account is @PReducoin.

Top 5 Casino Stocks To Own For 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Jason Hall, Chuck Saletta, and Reuben Gregg Brewer]

    But that doesn’t mean you need to make risky bets to capture solid returns, either, and buying solid companies at reasonable prices can help create a margin of safety and improve your returns, while also decreasing your risk of permanent losses. Three stocks that meet these criteria are small healthcare real-estate specialistCaretrust REIT Inc(NASDAQ:CTRE), financial services giantPrudential Financial Inc(NYSE:PRU), and energy behemothExxonMobil Corporation(NYSE:XOM).

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) takes such pride in its rock-solid financial condition that it uses an actual rock — the Rock of Gibraltar– as its corporate symbol. Prudential Financial backs up that claim with a balance sheet that has more cash, cash equivalents, and short-term investmentsthan total debt on it. It also claims a debt-to-equity ratio around 0.6 and a current ratio around 1.0, which are further signs of a solid financial condition.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its position in Prudential Financial Inc (NYSE:PRU) by 29.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 312,450 shares of the financial services provider’s stock after selling 132,238 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Prudential Financial worth $32,354,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    NN Investment Partners Holdings N.V. increased its holdings in Prudential Financial Inc (NYSE:PRU) by 0.1% during the 2nd quarter, Holdings Channel reports. The firm owned 2,197,076 shares of the financial services provider’s stock after buying an additional 2,780 shares during the period. Prudential Financial accounts for approximately 1.5% of NN Investment Partners Holdings N.V.’s portfolio, making the stock its 10th largest position. NN Investment Partners Holdings N.V.’s holdings in Prudential Financial were worth $205,450,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Symphony Asset Management LLC lowered its position in Prudential Financial Inc (NYSE:PRU) by 18.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,149 shares of the financial services provider’s stock after selling 3,765 shares during the period. Symphony Asset Management LLC’s holdings in Prudential Financial were worth $1,672,000 as of its most recent SEC filing.

Top 5 Casino Stocks To Own For 2019: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Jakks Pacific (NASDAQ:JAKK) from a sell rating to a hold rating in a research report released on Saturday.

    Several other brokerages have also recently weighed in on JAKK. Stifel Nicolaus lowered their target price on Jakks Pacific from $2.70 to $2.50 and set a hold rating on the stock in a report on Friday, April 27th. Zacks Investment Research cut Jakks Pacific from a hold rating to a sell rating in a report on Monday, April 30th. Finally, BMO Capital Markets restated a market perform rating and set a $2.50 target price (down from $3.50) on shares of Jakks Pacific in a report on Friday, February 23rd. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Jakks Pacific has a consensus rating of Hold and a consensus target price of $2.69.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on JAKKS Pacific (JAKK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    JAKKS Pacific, Inc. (NASDAQ:JAKK) – Equities research analysts at Jefferies Financial Group raised their Q2 2018 EPS estimates for JAKKS Pacific in a report issued on Monday, June 18th. Jefferies Financial Group analyst S. Wissink now expects that the company will earn ($0.50) per share for the quarter, up from their prior forecast of ($0.63). Jefferies Financial Group also issued estimates for JAKKS Pacific’s Q4 2018 earnings at ($0.31) EPS, FY2018 earnings at ($0.56) EPS, Q3 2019 earnings at $0.50 EPS and FY2019 earnings at $0.05 EPS.

Top 5 Casino Stocks To Own For 2019: Cushing Renaissance Fund (SZC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News coverage about CUSHING RENAISS/COM (NYSE:SZC) has been trending somewhat positive on Saturday, Accern reports. Accern identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CUSHING RENAISS/COM earned a news sentiment score of 0.06 on Accern’s scale. Accern also assigned media stories about the investment management company an impact score of 47.8560510338408 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

5 Best Supermarket Stocks For 2016

Stocks edged higher again today as the S&P 500 continued to flirt with its record high.

Getty Images

The S&P 500 climbed 0.3% and the Dow Jones Industrial Average added 67 points, or 0.4%. The Nasdaq Composite rose 0.3%. The S&P 500 is just 0.55% away from its record close of 2,130.82.

Deutsche Bank’s Alan Ruskin offers some reasons to “participate in the ‘risk bleed up’” in global markets:

i) Global risk appetite was trading very well even into the elevated expectations of a Fed rate hike (post April FOMC minutes, pre-May NFP) so the soft payroll data, delaying a Fed rate hike, fell on a receptive market, sympathetic to a positive risk scenario.

ii) Participation is low because the risk bleed up involves trading events that are not happening (no Fed rate hike and no China FX instability), which is normally less actively embraced than trading events that do happen (Fed rate hike, China FX instability). This reduced participation only gives the move more scope to run.

5 Best Supermarket Stocks For 2016: Mastercard Incorporated(MA)

MasterCard Incorporated, together with its subsidiaries, provides transaction processing and related services to customers principally in support of their credit, deposit access, electronic cash and automated teller machine payment card programs, and travelers? cheque programs. Its payment solutions include payment programs, marketing, product development, technology, processing, and consulting and information services. The company provides transaction processing services comprising transaction switching, which include authorization, clearing, and settlement; connectivity services, such as network access, equipment, and the transmission of authorization and settlement messages; and other payment-related services consisting of products used to prevent or detect fraudulent transactions, cardholder services, professional consulting and research services, compliance and penalty, account and transaction enhancement services, holograms, and publication services. MasterCard Incor porated manages and licenses payment card brands, including MasterCard, MasterCard Electronic, Maestro, and Cirrus. The company?s payment programs, which are facilitated through its brands, include consumer credit, debit and prepaid programs, commercial payment solutions, and contactless payment solutions. It serves approximately 22,000 financial institutions. The company was founded in 1966 and is headquartered in Purchase, New York.

Advisors’ Opinion:

  • [By Alex Planes]

    It was from these humble beginnings that Visa (NYSE: V  ) was born. BankAmericard became an independent corporation in 1970 and later changed its name to Visa in 1976 as a way to broaden its appeal internationally. By this point the Master Charge had been established as a competing credit card network, and it had actually grown larger than the former BankAmericard: In the first quarter of 1976, BankAmericard/Visa claimed 31.8 million cardholders and $2.3 billion in sales volume, while the Master Charge had 37.4 million cardholders and processed $2.9 billion in sales. Master Charge, of course, is the forerunner to MasterCard (NYSE: MA  ) , but it hasn’t maintained its early lead over Visa. In 2012, Visa’s total U.S. purchase volume clocked in at $981 billion compared to $534 billion for MasterCard, and Visa’s 278 million American cardholders far outweigh MasterCard’s 180 million American cardholders.

  • [By Rupert Hargreaves]

    Even so, thanks to its checkered past, many companies such as Visa (NYSE: V  ) andMasterCard (NYSE: MA  ) have been late to the party.However, astute companies, such asDeutsche Bank (NYSE: DB  ) have been active in the market since the mid 1970s.

5 Best Supermarket Stocks For 2016: Teva Pharmaceutical Industries Limited(TEVA)

 

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic medicines, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the womens health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinsons disease; Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders; Fentora庐/Effentora for the treatment of breakthrough pain in opioid-tolerant adult patients with cancer; and Zecuity, a prescription transdermal system for the acute treatment of migraine with or without aura in adults. This segments products in the respiratory market include ProAir, ProAir Respiclick, QVAR, and Duoresp Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda, Granix, Trisenox, Synribo, Lonquex, Myocet, Eporatio, Tevagrastim/Ratiograstim, and Trisenox products in the oncology market. This segment also offers a portfolio of products in the womens health category, which includes ParaGard, Plan B One-Step, OTC/Rx, Zoely, Seasonique, and Ovaleap, as well as other products. Teva Pharmaceutical Industries Limited has alliances and other arrangements with Takeda Pharmaceutical Company Limited and Procter & Gamble Company. The company was founded in 1901 and is headquartered in Petach ! Tikva, Israel.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Allerganmgmt is considering a range of capital deployment alternatives. The focus on the conference call was around future capital deployment. Mgmt remains highly optimistic the Teva Pharmaceutical Industries (TEVA) deal will close by late 1H16, noting both mgmt teams are absolutely aligned on getting the deal done and the deal proceeds will be after-tax net cash/equity of ~$36B. Mgmts is currently looking at a broad range of capital deployment options including debt pay down, share buyback and M&A. In our view,Allergan will likely put the TEVA proceeds to work through a mix of these options. The company has ~$6B of debt maturing in the next 2-years which it could look to repay and there are a few small to mid-size M&A targets thatAllergan could look to acquire. In terms of timing, mgmt commented that it would not hesitate for the right opportunity which suggests to us smaller bolt-on transactions arent gated by the completion of TEVA dea l.

  • [By Ben Levisohn]

    Johnson & Johnson (JNJ) now has a market cap of $308 billion dollars, just a smidgen less than that of Gilead Sciences (GILD), Biogen (BIIB), Mylan (MYL), Celgene (CELG) and Teva Pharmaceutical Industries (TEVA) combined. It’s time to sell, says Standpoint Research’s Ronnie Moas:

  • [By Johanna Bennett]

    UBSs Marc Goodman weighed in today on Teva Pharmaceuticals (TEVA) following yesterdays run by the stocks on the heels of the better-than-expected 1Q financial results by the drug maker.

    Offered up these highlight from the conference call with management, proclaiming that there are four things we believe investors need to hear.

    [Management sounds] confident in the AGN deal going through and has identified buyers for the majority of products to be divested. While divestitures are higher than expected, management will cut more costs to maintain the previously expected bottom line accretion. The U.S. generic drug pricing environment has not changed, and management still sees about 4% impact in 2016, which is similar to levels last year. The underlying base business for Teva is performing as expected, and it still expects sustainable growth in the global generics business of more than 5%. That includes a 10% gain from new products offset by a 5% hit from price/volume.

    Still, Goodman encourages investors to wait and see before buying the stock.

    Mgt sounded confident that the AGN generics deal should move forward, and Teva needs the cost synergies to help offset the potential Copaxone generic impact. But also Teva is significantly increasing its exposure to generics, as investors are incrementally more skeptical of the sector, so we would expect investors to take a wait and see attitude on numbers. In addition to the deal, the focus is on the generic challenges to Copaxone (IPR process/Sept trial), which we think will remain an overhang on the stock.

    Teva climbed more than 5% Monday and inched a bit higher today to trade at $52.85 in recent marker action. The shares have fallen 19.5% since the start of the year.

  • [By Ben Levisohn]

    Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:

Best Defense Companies To Buy For 2016: JAKKS Pacific, Inc.(JAKK)

 

JAKKS Pacific, Inc. designs, develops, produces, and markets consumer products in the United States and internationally. The companys Traditional Toys and Electronics segment offers action figures and accessories based on Batman, Star Wars, and Nintendo franchises; toy vehicles and accessories under the Road Champs, Fly Wheels, and MXS names; electronics products, such as video games under the Spy Net, Plug It In & Play TV Games, Disney, and Duck Commander brands names; fashion and baby dolls, and accessories under Disney Frozen, Disney Princess, Disney Fairies, Cabbage Patch Kids, and Graco licenses, as well as plush, infant, and pre-school toys based on PBSs Daniel Tigers Neighborhood name; private label products; foot-to-floor ride-on toys, and tents and wagons based on Fisher Price, Kawasaki, and DC Comics; and pet products, including toys, consumables, and accessories under the JAKKS Pets and American Classics brand names. Its Role Play, Novelty and Seasonal Toys segment offers role and pretend play, dress-up, and novelty products for boys and girls based on Disney Frozen, Black & Decker, McDonalds, Dirt Devil, Disney Princess, Disney Fairies, and Dora the Explorer licenses; indoor and outdoor kids furniture, activity trays and tables, room d茅cor, kiddie pools, and seasonal products based on Crayola and Disney names, as well as pool floats under the Funnoodle name; Halloween and everyday costumes, and accessories under Spiderman, Iron Man, Toy Story, Sesame Street, Power Rangers, and Hasbro, Disneys Frozen, and Disney Princess brands; and balls and sport sets, and toy hoops under the Skyball, Wave Hoops, and Maui Toys brand names. The company sells its products through in-house sales staff and independent sales representatives to toy and mass-market retail chain, department, office supply, club, and toy specialty stores; and drug and grocery store chains and wholesalers. JAKKS P acific, Inc. was founded in 1995 and is based in Malibu, Cal! ifornia.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One under-$10 toy player that’s trending very close to triggering a major breakout trade is Jakks Pacific (JAKK), which is a producer and marketer of children’s toys and other consumer products. This stock has been destroyed by the bears so far in 2013, with shares off sharply by 60%.

    If you take a look at the chart for Jakks Pacific, you’ll notice that this stock has been downtrending badly for the last two months and change, with shares plunging from its high of $11.75 to its recent low of $4.82 a share. During that downtrend, shares of JAKK have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of JAKK look like they might be ready to see an end to its downside volatility in the short-term if the recent lows can hold. I believe this due to the fact that JAKK has started to move sideways and trend within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in JAKK if it manages to break out above some near-term overhead resistance levels at $5.08 to $5.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 695,817 shares. If that breakout triggers soon, then JAKK will set up to re-test or possibly take out its next major overhead resistance levels at $5.68 to its 50-day moving average at $6.07 a share. Any high-volume move above its 50-day will then put $7 to $8 into range for shares of JAKK.

    Traders can look to buy JAKK off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.87 to $4.82 a share. One can also buy JAKK off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

5 Best Supermarket Stocks For 2016: Stamps.com Inc.(STMP)

 

Stamps.com Inc. provides Internet-based postage solutions in the United States. It offers solutions for mailing and shipping various mail pieces, such as postcards, envelopes, flats, and packages using a range of United States Postal Service (USPS) mail classes, including First Class Mail, Priority Mail, Priority Mail Express, Media Mail, Parcel Select, and others. The companys products and services comprise USPS approved PC Postage service that enables users to print electronic stamps directly onto envelopes, plain paper, or labels using personal computer, printer, and Internet connection. It also provides multi carrier shipping solutions under the ShipStation and ShipWorks brands; mailing and shipping integrations solutions comprising electronic postage for transactions to partners who manage the front-end process; sells NetStamps labels, DYMO Stamp labels, shipping labels, other mailing labels, dedicated postage printers, scales, and other mailing and shipping-focused office supplies through its mailing and shipping supplies store; and Stamps.com branded insurance to insure mails or packages. In addition, the company offers PhotoStamps, a patented form of postage service, which allows consumers to turn digital photos, designs, or images into USPS-approved postages. It serves individuals, small businesses, home offices, medium-size businesses, and large enterprises. The company was formerly known as StampMaster, Inc. and changed its name to Stamps.com Inc. in December 1998. Stamps.com Inc. was founded in 1996 and is headquartered in El Segundo, California.

Advisors’ Opinion:

  • [By Javier Hasse]

    Other stocks moving in Friday’s after-hours session included:

    A. O. Smith Corp (NYSE: AOS), down 2.5 percent Pan American Silver Corp. (USA) (NASDAQ: PAAS), down 2.1 percent Stamps.com Inc. (NASDAQ: STMP), up 1.87 percent

    Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

5 Best Supermarket Stocks For 2016: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of H untington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

    Caterpillar Inc. (NYSE: CAT) Jan17 77.5 Calls Sweep: 1022 @ ASK $4.45: 1066 traded vs 2466 OI: Earnings 7/28 $75.88 Ref Anacor Pharmaceuticals Inc (NASDAQ: ANAC) Jan17 110 Calls: 500 @ Above Ask! $0.40: 509 traded vs 1860 OI: $99.22 Ref Ctrip.com International, Ltd. (ADR) (NASDAQ: CTRP) Jun16 41.25 Calls Sweep: 577 @ ASK $1.75: 649 traded vs 1927 OI: Earnings 6/15 After Close $40.54 Ref Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Jun16 65.0 Calls Sweep: 749 @ ASK $1.85: 813 traded vs 370 OI: $63.08 Ref WhiteWave Foods Co (NYSE: WWAV) Oct16 50.0 Calls: 600 @ ASK $1.60: 601 traded vs 430 OI: $45.16 Ref

    Posted-In: Unusual Put OptionsNews Options Markets